肝脏硬度测定、血小板计数/脾厚比值和脾静脉直径预测肝硬化并发食管静脉曲张价值研究*

doi:10.3969/j.issn.1672-5069.2023.06.025

摘要/Abstract

摘要： 目的探讨肝脏硬度检测(LSM)、血小板计数(PLT)/脾脏厚度(ST)比值和脾静脉直径(SVD)预测肝硬化并发食管静脉曲张(EV)和侧支静脉曲张的效能。方法我院诊治的肝硬化患者94例,接受胃镜、超声内镜和FibroScan502检查。将EV分为无EV(NEV)、轻度EV、中度EV和重度EV。将食管周围静脉曲张(peri-ECV)分为无peri-ECV、轻度peri-ECV和重度peri-ECV,将食管旁侧支静脉曲张(para-ECV)分为无para-ECV、轻度para-ECV和重度para-ECV。应用ROC分析指标预测效能。结果与NEV患者比,中度和重度EV患者ST、SVD和LSM均显著升高(P＜0.05),而PLT和PLT/ST比值显著降低(P＜0.05);重度peri-ECV患者PLT和PLT/ST比值显著低于无或轻度peri-ECV患者(P＜0.05),而SVD和LSM水平显著高于轻度peri-ECV患者(P＜0.05);与无para-ECV患者比,轻度和重度para-ECV患者PLT和PLT/ST比值显著降低,而ST、SVD和LSM水平均显著升高(P＜0.05);经ROC曲线分析发现LSM诊断EV的AUROC为0.754,显著大于PLT/ST比值或SVD(分别为0.738和0.679);PLT/ST比值、LSM和SVD预测peri-ECV的效能均较低,其AUROC值均<0.600;PLT/ST比值预测para-ECV的效能显著优于LSM或SVD(AUROC为0.794对0.669或0.685)。结论应用LSM预测肝硬化并发EV或应用PLT/ST比值预测食管旁侧支静脉有一定的诊断价值,可在临床用于初筛检查,值得进一步验证。

关键词: 肝硬化, 静脉曲张, 肝脏硬度检测, 血小板计数, 脾厚度, 脾静脉直径, 诊断

Abstract: Objective The aim of this study was to investigate the diagnostic performance of liver stiffness measurement (LSM), platelet count (PLT) / spleen thickness (ST) ratio and splenic vein diameter (SVD) in predicting esophageal varices (EV)in patients with liver cirrhosis (LC). Methods We collected 94 patients with LC, and all patients completed gastroscopy and endoscopic ultrasonography. The EV were divided into non-EV (NEV), mild, moderate, and severe EV, the periesophageal varices (peri ECV) were divided into no peri ECV, mild and severe peri ECV, and the collateral esophageal veins (para-ECV) were divided into non-para-ECV, mild and severe para-ECV. The receiver operating characteristic (ROC) curve was applied to evaluate the predictive performance. Results The ST, SVD and LSM in patients with moderate and severe EV were significantly higher in patients with NEV (P<0.05), and the PLT counts and PLT/ST ratio were significantly lower in with NEV(P<0.05); the PLT and PLT/ST ratio in patients with severe peri-ECV were significantly lower than in patients without or with mild peri-ECV (P<0.05), while the SVD and LSM were significantly higher than in with mild peri-ECV (P<0.05); the PLT counts and PLT/ST ratio in patients with mild and severe para-ECV decreases greatly, while the ST, SVD and LSM increased greatly compared to in patients without para-ECV (P＜0.05); the ROC analysis showed that the AUROC was 0.754 by LSM in predicting EV, much superior to PLT/ST ratio or SVD(the AUROCs were 0.738 and 0.679, respectively); the predictive efficacy of PLT/ST ratio, LSM and SVD for peri-ECV were all poor with the AUROCs<0.600; the predictive efficacy of PLT/ST ratio in judging para-ECV was much superior to LSM or SVD(the AUROC was 0.794 vs. 0.669 or 0.685). Conclusion The LSM has a certain predictive efficacy for EV, and the PLT/ST ratio also has some efficacy for ECV in patients with LC, which might be applied for screening in clinical practice.

Key words: Liver cirrhosis, Esophageal varices, Liver stiffness measurement, Platelet, Spleen thickness, Splenic vein diameter, Diagnosis

刘欢, 陈鹏, 蒯文涛, 徐亮. 肝脏硬度测定、血小板计数/脾厚比值和脾静脉直径预测肝硬化并发食管静脉曲张价值研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 867-870.

Liu Huan, Chen Peng, Kuai Wentao, et al. Diagnostic performance of liver stiffness measurement, platelet / spleen thickness ratio and splenic vein diameter in predicting esophageal varices in patients with liver cirrhosis[J]. Journal of Practical Hepatology, 2023, 26(6): 867-870.

参考文献

[1] Rockey DC, Alan Elliott A, Lyles T. Prediction of esophageal varices and variceal hemorrhage in patients with acute upper gastrointestinal bleeding. J Investig Med, 2016,64(3):745-751.
[2] Fung BM, Abadir AP, Eskandari A, et al. Endoscopic ultrasound in chronic liver disease. World J Hepatol, 2020,12(6): 262-276.
[3] Kuramochi A, Imazu H, Kakutani H, et al. Color Doppler endoscopic ultrasonography in identifying groups at a high-risk of recurrence of esophageal varices after endoscopic treatment. J Gastroenterol, 2007,42:219-224.
[4] Manatsathit W, Samant H, Kapur S, et al. Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score in detection of esophageal varices: Systemic review and meta-analysis. J Gastroenterol Hepatol, 2018,33(10):1696-1706.
[5] Calvaruso V, Cacciola I, Licata A. Is transient elastography needed for noninvasive assessment of high-risk varices? The REAL experience. Am J Gastroenterol, 2019,114(8):1275-1282.
[6] Tosetti G, Massimo Primignani M, Mura VL,et al. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.Dig Liver Dis, 2019,51(8):1135-1140.
[7] 中华医学会外科学分会脾及门静脉高压外科学组.肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019年版).中华消化外科杂志,2019,34(12):1087-1093.
[8] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南.临床肝胆病杂志,2016,32(2):203-219.
[9] 孙若楠,张春清.食管胃底静脉曲张破裂出血预防和治疗进展.实用肝脏病杂志,2021,24(4):607-610.
[10] Mahmood K, Haider I, Adil SO,et al. Non-invasive assessment of large esophageal varices with liver cirrhosis; a study conducted in Pakistan. J Med Invest, 2019,66(3-4):248-251.
[11] 王春妍,文君,周永和,等.声脉冲辐射力弹性成像技术对乙型肝炎后肝硬化患者EV的预测价值.中华肝脏病杂志,2018,26(7):499-502.
[12] Katwyk SV, Coyle D, Cooper C,et al. Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations. Liver Int, 2017,37(6):851-861.
[13] Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology, 2007,45(5):1290-1297.
[14] Romeo-Gabriel M. Liver stiffness in chronic hepatitis C virus infection. Rom J Intern Med, 2019,57(2):85-98.
[15] Zaghloul SG, Wahab EA, Seleem WM, et al. Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis C virus-related liver cirrhosis. Observatl Stu Drug Discov Ther, 2019,13(2):108-113.
[16] Muñoz-Codoceo C, Amo M, Martín A, et al. Diagnostic accuracy of liver and spleen stiffness measured by fibroscan© in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals. Gastroenterol Hepatol, 2020,S0210-5705(20)30321-30326.
[17] Sigal SH, Sherman Z, Jesudian A. Clinical implications of thrombocytopenia for the cirrhotic patient. Hepat Med, 2020,14(12):49-60.
[18] Wang JH, Chuah SK, Lu SN, et al. Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus-related cirrhosis. J Gastroenterol Hepatol, 2012,27(7):1213-1218.
[19] Kumar P, Singh K, Joshi A, et al. Evaluation of non-invasive marker of esophageal varices in cirrhosis of liver. J Family Med Prim Care, 2020,9(2):992-996.
[20] Zhao W, Liu C, Zhang L, et al. Application of shear wave elastography as a diagnostic method for esophageal varices. Ann Palliat Med, 2020, apm-20-306.

肝脏硬度测定、血小板计数/脾厚比值和脾静脉直径预测肝硬化并发食管静脉曲张价值研究^*

Diagnostic performance of liver stiffness measurement, platelet / spleen thickness ratio and splenic vein diameter in predicting esophageal varices in patients with liver cirrhosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	邵孝如, 周筱, 葛颖颖. ¹⁸F-FDG摄取量诊断非酒精性脂肪性肝病患者罹患冠状动脉粥样硬化性心脏病探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 811-814.
[2]	丁晓洁, 张永明, 宋海燕, 王文平, 宋洁, 撒小军, 邹永红. 2型糖尿病合并非酒精性脂肪性肝病患者NLR和PLR变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 815-818.
[3]	阎道博, 朱海超, 闪海霞. 瞬时弹性成像联合APRI诊断自身免疫性肝炎患者肝纤维化效能研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 831-834.
[4]	邹涛, 张敏, 杨凡, 王丽, 喻峰. 慢性乙型肝炎和乙型肝炎肝硬化患者PBMCs 信号转导和转录激活因子3及血清可溶性CD30分子水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 855-858.
[5]	田宇, 陈燕, 曹佳非, 周晓倩. 肝硬化并发肝肾综合征患者U-mAl及外周血NLR和血清NGAL水平变化研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 859-862.
[6]	姜亚超, 尹力, 颜状. “改良三明治夹心法”行ESVD术治疗肝硬化并发食管胃静脉曲张患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 863-866.
[7]	贺梅年, 赵思佳, 田智超, 何秀英, 巴正武. 超声半定量评分结合弹性成像诊断慢性乙型肝炎患者早期肝硬化临床价值分析^*[J]. 实用肝脏病杂志, 2023, 26(6): 871-874.
[8]	杨帆, 张小娟, 李丹, 姜莎莎, 张亮, 唐伟, 赵微. 胃镜下硬化术联合组织胶注射术治疗乙型肝炎肝硬化并发食管胃静脉曲张破裂出血患者1年再出血危险因素分析^*[J]. 实用肝脏病杂志, 2023, 26(6): 875-878.
[9]	莫春明, 黄德佳, 韦惠章, 罗江伟. TACE术治疗的原发性肝癌患者血清IL-33水平变化及其对发热的鉴别意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 887-890.
[10]	周莉, 丁云清, 袁凤英, 陈竹, 冯志伟. 超声造影判断乙型肝炎肝硬化患者肝内占位性病变性质价值研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 903-906.
[11]	刘明, 王金婷, 杨士彦, 杨位轩, 万元春. ESPBD与EST治疗肝硬化合并胆总管结石患者疗效比较^*[J]. 实用肝脏病杂志, 2023, 26(6): 915-918.
[12]	张蕊, 时倩倩, 王仲秋. DCE-MRI、DWI和MRCP联合诊断肝外胆管癌临床价值研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 923-926.
[13]	黄柏盛, 区蓝芯, 张莹洁, 方梦冰, 施梅姐, 黎胜, 萧焕明. FibroScan联合GPR、APRI和FIB-4诊断血清ALT正常的慢性HBV感染者肝纤维化价值分析^*[J]. 实用肝脏病杂志, 2023, 26(5): 618-621.
[14]	郝岸华, 杜忠彩, 周林, 马磊. 慢性乙型肝炎患者肝脏硬度检测和S指数变化及评估肝纤维化程度应用价值探讨^*[J]. 实用肝脏病杂志, 2023, 26(5): 630-633.
[15]	刘爱华, 符建, 陈小红. 瞬时超声弹性成像联合GGT/PLT比值预测慢性乙型肝炎患者肝纤维化价值研究^*[J]. 实用肝脏病杂志, 2023, 26(5): 634-637.